Trials / Completed
CompletedNCT05881707
A Clinical Trial to Compare the Pharmacokinetic and Safety of CKD-828 20/1.25mg
A Randomized, Open-label, Single Dose, 4-period Replicate Crossover Study to Evaluate the Pharmacokinetic Profiles and Safety of CKD-828 in Healthy Volunteers Under Fasting Conditions
- Status
- Completed
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 44 (actual)
- Sponsor
- Chong Kun Dang Pharmaceutical · Industry
- Sex
- All
- Age
- 19 Years – 54 Years
- Healthy volunteers
- Accepted
Summary
A clinical trial to compare the pharmacokinetic and safety of CKD-828 20/1.25mg
Detailed description
A randomized, open-label, single dose, 4-period replicate crossover study to evaluate the pharmacokinetic profiles and safety of CKD-828 in healthy volunteers under fasting conditions
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | CKD-828, D064, D702 | QD, PO |
Timeline
- Start date
- 2023-07-04
- Primary completion
- 2023-09-02
- Completion
- 2023-09-27
- First posted
- 2023-05-31
- Last updated
- 2023-10-31
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT05881707. Inclusion in this directory is not an endorsement.